Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Hydrofarm Holdings Group Reports Disappointing Fourth Quarter 2023 Financial Results

Elaine Mendonca by Elaine Mendonca
February 29, 2024
in Breaking News
0
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Hydrofarm Holdings Group (NASDAQ: HYFM) announced their fourth-quarter 2023 financial results on February 29, 2024. The company reported a GAAP EPS of $(0.33), which was 14 cents below the analyst consensus estimate. Quarterly sales were $47.18 million, falling short of the expected $51.43 million by 8.26%. This marks a 23.23% decrease from sales of $61.46 million in the same period last year. The earnings report highlights a tough quarter for Hydrofarm Holdings Group, with disappointing sales and earnings performance.

HYFM Stock Update: February 29, 2024 Analysis and Insights

On February 29, 2024, HYFM stock experienced a slight decrease in price, closing at $0.87, which was a drop of 1.15% from the previous market close. Despite this decrease, the stock showed some resilience in after-hours trading, rising by $0.01.

One key indicator of HYFM’s performance is its position relative to its 52-week range and its 200-day simple moving average. As of February 29, HYFM was trading in the middle of its 52-week range and below its 200-day simple moving average. This suggests that the stock may be experiencing some level of stability.

Investors should consider these factors when evaluating HYFM’s performance. While the slight drop in price on February 29 may be a cause for concern for some investors, the stock’s ability to rebound in after-hours trading could be seen as a positive sign.

Overall, HYFM’s performance on February 29, 2024, reflects a mix of both positive and negative indicators. Investors should continue to monitor the stock’s movements and consider the broader market conditions when making investment decisions.

HYFM Stock Financial Performance Declines Significantly in 2024 – Analysis and Insights

On February 29, 2024, HYFM stock experienced a significant decline in its financial performance compared to the previous year and quarter. According to data from CNN Money, the company reported a total revenue of $344.50 million for the past year, which represents a decrease of 28.14% compared to the previous year. In the third quarter of the fiscal year, the total revenue was $54.17 million, showing a decrease of 14.09% compared to the previous quarter.

Similarly, the net income of HYFM also saw a drastic decline in performance. The company reported a net income of -$285.42 million for the past year, marking a significant decrease of 2227.42% compared to the previous year. In the third quarter, the net income was reported as -$19.88 million, showing a decrease of 54.56% compared to the previous quarter.

Furthermore, the earnings per share (EPS) of HYFM also experienced a sharp decline in performance. The EPS was reported as -$6.35 for the past year, indicating a decrease of 2133.35% compared to the previous year. In the third quarter, the EPS was reported as -$0.44, showing a decrease of 53.9% compared to the previous quarter.

Overall, the financial performance of HYFM stock on February 29, 2024, reflects a challenging period for the company, with significant declines in total revenue, net income, and earnings per share. Investors and analysts will closely monitor the company’s future strategies and performance to assess its ability to recover from these setbacks and regain investor confidence.

Tags: HYFM
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Technology Data analytics stock Trading (1)

Analyst Peter Weed Reiterates Market Perform Rating on Okta

Finance_ Trading ratings today (2)

Analyst Maintains Neutral Rating on Clearwater Analytics Holdings with 20 Price Target

Energy Company Markets and money

Analyst Views and Forecasts on DrilQuip A Comprehensive Analysis

Recommended

Gold Stock

Gold Nears Historic Peak as Market Anticipation Builds

2 months ago
Dentist

Advancements in Oral Healthcare: The Business Impact of Highly Trained Surgeons

2 years ago
Archer Aviation Stock

Archer Aviation Strengthens Market Position Through Strategic Patent Acquisition

4 months ago
SNDR stock news

Yousif Capital Management LLC Reduces Stake in Steven Madden, Ltd.: Implications for the Company’s Future Performance

3 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Graftech Shares Plunge on Bleak Quarterly Results

Potbelly Accelerates Northeast Growth with New Jersey Franchise Push

Conduent Faces Mounting Fallout from Major Data Breach Ahead of Earnings

Blue Ridge Bankshares Emerges from Regulatory Challenges with Return to Profitability

Navigating the Interest Rate Tightrope: Bank7’s Path Forward

Trending

Design Therapeutics Stock
Analysis

Design Therapeutics Approaches Key Clinical Milestones with Ample Funding

by Rodolfo Hanigan
February 7, 2026
0

Investor attention is turning to the upcoming catalysts for Design Therapeutics, a biotechnology firm advancing its GeneTAC...

Vigil Neuroscience Stock

Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy

February 7, 2026
Repay Holdings Stock

Repay Holdings: Annual Report to Test Strategic Refinancing Success

February 7, 2026
Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

Amazon’s $200 Billion Penalty, The Bad News Rally, and A Cloud Divorce

February 7, 2026
Graftech Stock

Graftech Shares Plunge on Bleak Quarterly Results

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Design Therapeutics Approaches Key Clinical Milestones with Ample Funding
  • Sanofi Completes Vigil Neuroscience Acquisition, Eyes Alzheimer’s Therapy
  • Repay Holdings: Annual Report to Test Strategic Refinancing Success

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com